The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs

Authors :: Laura Tucker
Alexander Allen
David Chandler
Coziana Ciurtin
Andrew Dick
Amy Foulkes
Nicola Gullick
Philip Helliwell
Deepak Jadon
Gareth Jones
Stuart Kyle
Vishnu Madhok
Neil McHugh
Andrew Parkinson
Tim Raine
Stefan Siebert
Catherine Smith
William Tillett
Laura C Coates
Source :: Tucker, L, Allen, A, Chandler, D, Ciurtin, C, Dick, A, Foulkes, A, Gullick, N, Helliwell, P, Jadon, D, Jones, G, Kyle, S, Madhok, V, McHugh, N, Parkinson, A, Raine, T, Siebert, S, Smith, C, Tillett, W & Coates, L C 2022, ' The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs ', Rheumatology (Oxford, England), vol. 61, no. 9, keac295, pp. e255-e266 . https://doi.org/10.1093/rheumatology/keac295
Publication Year :: 2022

Subjects :: Biological Products
dactylitis
treatment
enthesitis
Arthritis, Psoriatic
psoriasis
targeted synthetic DMARDs
PsA
Rheumatology
Antirheumatic Agents
recommendations
Humans
biologics
Pharmacology (medical)
guideline
management

Language :: English
Database :: OpenAIRE
Journal :: Tucker, L, Allen, A, Chandler, D, Ciurtin, C, Dick, A, Foulkes, A, Gullick, N, Helliwell, P, Jadon, D, Jones, G, Kyle, S, Madhok, V, McHugh, N, Parkinson, A, Raine, T, Siebert, S, Smith, C, Tillett, W & Coates, L C 2022, ' The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs ', Rheumatology (Oxford, England), vol. 61, no. 9, keac295, pp. e255-e266 . https://doi.org/10.1093/rheumatology/keac295
Accession number :: edsair.doi.dedup.....369b113a0ea5f8d248636bd65020bb1b

Tools